Now showing items 1-6 of 6
Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease.
(Congenit Heart Dis, 2012-07)
BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia in adults with congenital heart disease (CHD). Long-term antiarrhythmic therapy (AAT) in these patients has significant shortcomings. The safety and efficacy of ...
Partial anomalous pulmonary venous connection and pulmonary arterial hypertension.
BACKGROUND AND OBJECTIVE: Isolated partial anomalous pulmonary venous connection (PAPVC) has been implicated as a cause of pulmonary arterial hypertension (PAH); however this condition is often overlooked in the diagnostic ...
Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension.
(Am J Cardiol, 2012-09-15)
Brain natriuretic peptide (BNP) levels are lower in obese patients with left ventricular failure than in their comparably ill, leaner counterparts. The effect of obesity on BNP in patients with pulmonary arterial hypertension ...
Off-label closure during CLOSURE study.
(J Invasive Cardiol, 2012-11)
BACKGROUND: The role of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke or transient ischemic attack remains controversial. Registry data have suggested considerable benefit of closure ...
Lateral caval flap repair of adult sinus venosus atrial septal defect: A natural novel approach.
(J Thorac Cardiovasc Surg, 2012-10)
Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure.
(JACC Cardiovasc Interv, 2012-04)
OBJECTIVES: This study was designed to assess the prevalence of provoked exercise desaturation (PED) in patients with patent foramen ovale (PFO) referred for cardiovascular evaluation and to evaluate the impact of PFO closure. ...